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Summary
Introduction: Nasal NK/T-cell lymphoma is a rare but well-known clinical entity. Thanks to
improvements in anatomopathology and the development of routine immunohistochemistry, the
diagnosis of nasal NK/T-cell lymphoma (NK for ‘‘natural killer’’) was recognized by the WHO in
2001. The main differential diagnosis is with Wegener’s granulomatosis. Treatment is based on
radiotherapy and chemotherapy. Prognosis is poor, with variable evolution and sometimes rapid
progression.
Case report: The authors report the case of a 54-year-old man without known pathological
history, who presented with bilateral nasal obstruction with purulent rhinorrhea. Diagnosis was
made on the basis of immunohistochemical study of biopsy samples. The tumor was graded
IE on the Ann Arbor classiﬁcation. Treatment, comprising CHOP chemotherapy followed by
radiotherapy, achieved total remission at 8 months’ follow-up.
Discussion/Conclusion: Sinonasal NK/T-cell lymphoma is rare. Diagnosis is based on immunophe-
notypic and molecular characteristics. It is an aggressive lymphoma, requiring multidisciplinary
management. Prognosis is poor.
© 2012 Elsevier Masson SAS. All rights reserved.
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Nasal NK/T-cell lymphoma, formerly known as malignant
centrofacial granuloma, is a rare clinicopathologic entity
characterized by a necrotic process originating in the nasal
cavity and extending to the medio-facial bone structures
with centrifugal destruction of the facial bone. The advent
of immunohistochemistry enabled its recognition by the
WHO in 2001. Evolution is spontaneously fatal. Treatment
is based on radiotherapy and chemotherapy.Sinonasal locations are rare. We report one such case and
discuss the speciﬁcities of this location.
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54-year-old man without known pathological history pre-
ented with bilateral nasal obstruction of progressive onset,
ssociated with fetid bilateral purulent rhinorrhea and
pper dysphagia of 5 months’ evolution in a context of
pyrexia and 4 kg weight-loss over 3 months.
ENT examination found a ﬂeshy burgeoning polypoid for-
ation, bleeding on contact and ﬁlling the entire right nasal
avity, pushing back the ipsilateral middle turbinate and
asal septum. Endoscopy was impossible due to the size of
he mass. Oral cavity examination found hard palate ulcer-
tion (Fig. 1). Otherwise, clinical examination, notably of
he lymph-node regions, was normal.
Bacteriological examination of the secretions, sampled
y direct swabbing of the nasal cavities, was negative.
inonasal CT found ﬁlling of the maxillary sinuses and right
served.
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Figure 3 Immunohistochemical staining: Intense diffuse
membrane stain on CD3, no clear stain on CD20, and moderate
marking of large tumor cells on CD 56.
Table 1 Ann Arbor classiﬁcation.
Stage I
Involvement of a single lymph-node region
IE: Involvement of a single extranodal organ or site
Stage II
Involvement of two or more lymph-node regions or
lymphatic structures on the same side of the diaphragm
IIE: localized extranodal extension with one or more
lymph-node regions on the same side of the diaphragm
Stage III
Involvement of lymph-node regions on both sides of the
diaphragm
IIIS: with spleen involvement
IIIE: with localized extranodal extensionFigure 1 Hard palate ulceration.
asal cavity with lysis of the medial wall of the right max-
llary sinus and ﬂoor of the right nasal cavity (Fig. 2a and
).
Histopathologic analysis of biopsy samples from the right
asal cavity and hard palate, taken under general anes-
hesia, found friable tissue with necrotic areas, suggestive
f infectious or tumoral pathology, without being able to
ecide between the two. Immunohistochemistry diagnosed
inonasal NK/T-cell lymphoma. The lymphoid elements were
ositive for cytoplasmic CD3, negative for pan-cytokeratin
nd positive for CD56 (Fig. 3).
Extension assessment, comprising chest X-ray,
horacic-abdominal-pelvic CT, digestive ﬁbroscopy and
steomedullary biopsy, was negative. Biological analysis
as normal, and TPHA-VDRL, HIV and EBV serology was
egative. The lymphoma was graded IE on the Ann Arbor
lassiﬁcation (Table 1).Treatment consisted in adjuvant polychemotherapy,
ith ﬁve CHOP cycles (doxorubicin, vincristine, cyclophos-
hamide and prednisone), followed by locoregional external
igure 2 a: axial CT slice: homogeneous tissue process ﬁlling
he maxillary sinuses and extending to the right nasal cavity;
: coronal CT slice: tissue process of the maxillary sinuses and
ight nasal cavity with bone destruction in the medial wall of
he right maxillary sinus and nasal cavity ﬂoor.
Stage IV
Diffuse or disseminated involvement of one or more
extranodal regions (liver, lung, bone marrow, bone)
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adiotherapy (paranasal sinus and nasal cavities: 48.6 GY
n 27 sessions). At 8 months’ follow-up, the patient was in
omplete clinical and radiological remission.
iscussion
inonasal NK/T-cell lymphoma is rare, but more common in
sia, Mexico and South America than in Europe and North
merica [1]. There have been a few reports concerning this
ocation [2—4]. Onset is usually during the 5th decade of
ife in Western countries [3,4]; in Asia, patients are younger,
ith a mean age of 40 years, and show male predominance
sex ratio, 2/3) [4,5].
Clinical presentation largely consists of local signs such
s unilateral nasal obstruction, purulent and/or blood-
treaked rhinorrhea, recurrent epistaxis or chronic sinusitis
4,6]. General signs, such as fever, weight-loss or night
weats, are rare and concern advanced stages. Signs of
egional extension (jaw swelling or ophthalmic, auditory,
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pharyngeal or neurological disorder) may be the presenting
symptoms [4].
Clinical examination generally ﬁnds an anterior
ulceronecrotic lesion, bleeding on contact and ﬁlling
the nasal cavity, usually located on the lateral wall [4,7].
Lymph-node involvement varies from series to series and
never exceeds 25% of cases [4,8].
CT guides diagnosis, often ﬁnding an aspect suggestive of
solid tumor with little if any contrast uptake. Bone structure
destruction is found in less than half of cases and especially
in case of large tumor.
MRI contributes to assessment of extension to adja-
cent structures, differentiating tumoral from inﬂammatory
processes. Biological analysis systematically ﬁnds an inﬂam-
matory syndrome.
Diagnosis is conﬁrmed by histologic and immunohisto-
chemical biopsy analysis. Immunohistochemistry determines
lymphoid element phenotype and is essential to diagno-
sis. NK etiology is conﬁrmed from expression of CD2, CD56
and cytotoxicity markers (T1a, Granzyme B, perforin); CD5,
CD4 and CD8 are negative; CD3 expression is variable
(absence of superﬁcial CD3 marker) [7]. Association with
EBV is almost systematic. In the present case, only the
immunohistochemical study provided certainty. There is a
problem of differential diagnosis with respect, for example,
to Wegener’s granulomatosis [4].
Treatment for sinonasal NK/T-cell lymphoma is not as
yet well codiﬁed, and depends mainly on the stage of
the disease. Some teams generally use anthracycline-based
polychemotherapy followed by external radiation consoli-
dation therapy for patients younger than 60 years of age
and the same association but without anthracycline in older
patients [1]. Others still recommend radiation therapy alone
in less advanced stages, as the failure rate in primary
chemotherapy reaches 40%. Radiation therapy following fail-
ure of chemotherapy is associated with improved prognosis
[9]. Overall survivorship for all treatment modalities taken
together is around 37% [7].
ConclusionSinonasal locations for NK/T-cell lymphoma are rare.
Diagnosis is founded on immunohistochemistry. Treatment
associates chemo- and radiotherapy. Overall prognosis is
poor, even with treatment. The major issue at present is to
[147
tandardize treatment protocols in multidisciplinary team-
ork between oncohematologists and ENT physicians.
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